IKT

Inhibikase Therapeutics, Inc. IKT

$2.17 -0.06 (-2.69%)

Extended · +1.10σ

+ Compare Open in Sniper

Mkt cap $0.4B

P/E —

Day $2.15 – $2.25

52wk $1.49 – $2.36

Avg vol —

Beta —

Div yld —

Next earnings —

Quick read

At a glance

Inhibikase Therapeutics, Inc. is a healthcare company listed in the US.

IKT last traded at $2.17, down 2.7% on the day; that's in the upper part of its 52-week range ($1.49–$2.36). Right now it's trading above its recent average — momentum is positive, though some of the move may already be in the price.

Earnings reports are the biggest scheduled catalysts to keep an eye on, and after a strong run, watch whether the price can hold its gains on quieter days.

A quick snapshot built from the data on this page — not investment advice. Always do your own research.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Valuation & accounting

Valuation desk →

The model's verdict is “Unknown” and accounting quality screens as Adequate. Model estimates only — do your own due diligence.

Unknown Accounting: Adequate

Accounting quality Adequate

✓ More cash than debt
✓ Current ratio 21.70 (antifragile)
✓ Debt/equity 0.05 (antifragile)

⚠ Negative retained earnings

Key statistics

All statistics →

IKT is a $350 million company.

Market cap $0.4B

P/E ttm —

Beta —

52w range $1.49 – $2.36

Avg volume —

Dividend yield —

Sector Healthcare

Next earnings —

52-week range · today's price

$1.49$2.36